Investigating Coenzyme Q's effects on ADHD in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the role of Coenzyme Q in treating Attention Deficit Hyperactivity Disorder (ADHD) in children. It involves administering Atomoxetine alongside Coenzyme Q to assess any potential benefits in managing ADHD symptoms. The study aims to determine if the addition of Coenzyme Q can enhance treatment outcomes for children diagnosed with ADHD. The trial is designed as a Phase 3 interventional study, focusing on a specific patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with ADHD

Exclusion Criteria:

* Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.

Where it's running

• Sherief Abd-Elsalam
  Tanta, Egypt Recruiting

Study contacts

• Principal investigator: Fatma G. Abdelkader, Msc — Pediatrics department - Kafr Elsheikh University
• Study coordinator: Sherief Abd-Elsalam, ass. prof.
• Email: sheriefabdelsalam@yahoo.com
• Phone: 00201147773440

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict medication-related side effects in children with ADHD

  This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07900451

• Group CBT vs. Activity Group for Adults with ADHD

  This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

  Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

• Central Executive Training and Behavioral Parent Training for Young Children with ADHD

  This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.

  Recruiting Florida State University · Tallahassee, Florida · NCT07784348

• Solriamfetol for ADHD in teens: see if it helps with focus

  This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.

  Recruiting at 31 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 30 other locations · NCT07717892

• Solriamfetol for children with ADHD: a 6-week comparison to placebo

  This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.

  Recruiting at 32 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 31 other locations · NCT07717879

• Impact of Sleep Timing and Duration on Teens with ADHD

  This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07684417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.